Edition:
United Kingdom

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

0.36USD
18 May 2018
Change (% chg)

-- (--)
Prev Close
$0.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,611
52-wk High
$2.83
52-wk Low
$0.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.14 -0.611
Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.22 0.52 0.00 --
Quarter Ending Sep-18 3 0.67 1.87 0.00 --
Year Ending Dec-18 3 2.18 5.00 0.56 0.78
Year Ending Dec-19 3 3.22 8.50 0.00 18.25
Earnings (per share)
Quarter Ending Jun-18 3 -0.29 -0.06 -0.48 -0.46
Quarter Ending Sep-18 3 -0.26 -0.06 -0.45 -0.50
Year Ending Dec-18 3 -1.14 -0.42 -1.83 -2.33
Year Ending Dec-19 3 -0.30 -0.24 -0.34 -2.85
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.57 32.53
P/E High - Last 5 Yrs. -- 41.44 47.11
P/E Low - Last 5 Yrs. -- 23.40 24.61
Beta 0.44 0.80 0.79
Price to Sales (TTM) 8.57 4.06 8.85
Price to Book (MRQ) -- 3.49 4.22
Price to Tangible Book (MRQ) -- 4.40 5.79
Price to Cash Flow (TTM) -- 19.79 21.98
% Owned Institutions 9.40 1.27 2.39

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.12
Payout Ratio(TTM) -- 16.85 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -17.34 3.97 5.06
Sales (TTM) vs TTM 1 Yr. Ago -85.81 10.12 12.43
Sales - 5 Yr. Growth Rate -55.71 7.45 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 23.97 37.00 32.52
EPS (TTM) vs TTM 1 Yr. Ago 50.34 -- --
EPS - 5 Yr. Growth Rate -- 7.09 8.54
Capital Spending - 5 Yr. Growth Rate -- 8.30 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) 0.49 3.58 3.56
LT Debt to Equity (MRQ) -- 10.34 12.76
Total Debt to Equity (MRQ) -- 12.69 15.69
Interest Coverage (TTM) -- 40.07 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.56 54.71
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) -3,259.08 -- --
EBITD - 5 Yr. Avg -848.96 18.51 15.91
Operating Margin (TTM) -3,270.27 13.07 -1.83
Operating Margin - 5 Yr. Avg. -854.16 14.25 11.18
Pre-Tax Margin (TTM) -3,059.72 13.35 0.25
Pre-Tax Margin - 5 Yr. Avg. -829.56 14.52 11.38
Net Profit Margin (TTM) -3,075.99 9.76 -3.16
Net Profit Margin - 5 Yr. Avg. -832.18 10.80 7.67
Effective Tax Rate (TTM) -- 22.46 31.64
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) 31,480 836,134,495 726,901,196
Net Income/Employee (TTM) -968,320 97,299,163 84,519,443
Receivable Turnover (TTM) 17.49 5.53 5.67
Inventory Turnover (TTM) -- 2.49 3.53
Asset Turnover (TTM) 0.06 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -171.61 10.46 9.99
Return on Assets - 5 Yr. Avg. -79.75 11.69 11.11
Return on Investment (TTM) -754.61 13.08 12.63
Return on Investment - 5 Yr. Avg. -105.51 15.12 14.39
Return on Equity (TTM) -- 14.80 14.50
Return on Equity - 5 Yr. Avg. -604.87 16.36 15.75
  1 Year 3 Year 5 Year
Sales % -85.81 -0.54 -55.71
EPS (TTM) % 39.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 34.40%
# of Holders: 28
Total Shares Held: 26,700,336
3 Mo. Net Change: 21,935,171
# New Positions: 9
# Closed Positions: 4
# Increased Positions: 15
# Reduced Positions: 5
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.